Home Cart 0 Sign in  
X

[ CAS No. 75151-82-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 75151-82-5
Chemical Structure| 75151-82-5
Chemical Structure| 75151-82-5
Structure of 75151-82-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 75151-82-5 ]

Related Doc. of [ 75151-82-5 ]

Alternatived Products of [ 75151-82-5 ]

Product Details of [ 75151-82-5 ]

CAS No. :75151-82-5 MDL No. :MFCD02673565
Formula : C11H15NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ICMIOUKQLCKMHC-UHFFFAOYSA-N
M.W : 193.24 Pubchem ID :4186956
Synonyms :

Calculated chemistry of [ 75151-82-5 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 56.94
TPSA : 49.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.97 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.93
Log Po/w (XLOGP3) : 2.13
Log Po/w (WLOGP) : 2.19
Log Po/w (MLOGP) : 1.83
Log Po/w (SILICOS-IT) : 1.63
Consensus Log Po/w : 1.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.5
Solubility : 0.612 mg/ml ; 0.00317 mol/l
Class : Soluble
Log S (Ali) : -2.8
Solubility : 0.308 mg/ml ; 0.00159 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.04
Solubility : 0.178 mg/ml ; 0.00092 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.36

Safety of [ 75151-82-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338-P280 UN#:N/A
Hazard Statements:H317-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 75151-82-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 75151-82-5 ]
  • Downstream synthetic route of [ 75151-82-5 ]

[ 75151-82-5 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 75151-82-5 ]
  • [ 74-88-4 ]
  • [ 56619-93-3 ]
YieldReaction ConditionsOperation in experiment
91% With potassium carbonate In acetone for 3 h; Heating / reflux Synthesis of N-(3-methoxyphenyl)pivalamide
Into a 1000 mL round-bottom flask, was placed a solution of N-(3-hydroxyphenyl)pivalamide (13.4 g, 69.43 mmol, 1.00 equiv) in acetone (500 mL).
To this was added K2CO3 (28.5 g, 206.52 mmol, 3.00 equiv).
To the mixture was added MeI (39.4 g, 277.46 mmol, 4.00 equiv).
The resulting solution was allowed to react, with stirring, for 3 h while the temperature was maintained at reflux in a bath of oil.
The reaction progress was monitored by TLC (EtOAc/PE=1:2).
A filtration was performed.
The filtrate was concentrated by evaporation under vacuum using a rotary evaporator.
The resulting mixture was washed with hexane.
A filtration was performed.
This resulted in 13.9 g (91percent) of N-(3-methoxyphenyl)pivalamide as a white solid.
91% With potassium carbonate In acetone for 3 h; Heating / reflux Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3 x 300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.
91% With potassium carbonate In acetone for 3 h; Heating / reflux Synthesis of N-(3-methoxyphenyl)pivalamide
Into a 1000 mL round-bottom flask, was placed a solution of N-(3-hydroxyphenyl)pivalamide (13.4 g, 69.43 mmol, 1.00 equiv) in acetone (500 mL).
To this was added K2CO3 (28.5 g, 206.52 mmol, 3.00 equiv).
To the mixture was added MeI (39.4 g, 277.46 mmol, 4.00 equiv).
The resulting solution was allowed to react, with stirring, for 3 h while the temperature was maintained at reflux in a bath of oil.
The reaction progress was monitored by TLC (EtOAc/PE=1.2).
A filtration was performed.
The filtrate was concentrated by evaporation under vacuum using a rotary evaporator.
The resulting mixture was washed with hexane.
A filtration was performed.
This resulted in 13.9 g (91percent) of N-(3-methoxyphenyl)pivalamide as a white solid.
91% With potassium carbonate In acetone for 3 h; Reflux 2. Synthesis of N-(3-methoxyphenyl)pivalamide; Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3.x.300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.
91% With potassium carbonate In acetone for 3 h; Reflux 2. Synthesis of 7V-(3-methoxyphenyl)pivalamide.Methyl iodide (277 mmol) was added to a suspension of 7V-(3 -hydro xyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3 x 300 mL) and the combined extracts were concentrated to provide 7V-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.
91% With potassium carbonate In acetone for 3 h; Reflux Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3.x.300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid
91% With potassium carbonate In acetone for 3 h; Reflux 2. Synthesis of 7V-(3-methoxyphenyl)pivalamide. Methyl iodide (277 mmol) was added to a suspension of 7V-(3-hydroxyphenyl)pivalamide(69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3 x 300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid. 3. Synthesis of iV-(2-(2-hvdroxyethv0-3-methoxyphenyl)pivalamide.
91% With potassium carbonate In acetone for 3 h; Reflux Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h.
The insoluble solids were removed by filtration and the filtrate was concentrated.
The residue was extracted with hexane (3*300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.

Reference: [1] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
[2] Patent: US2008/318941, 2008, A1, . Location in patent: Page/Page column 38-39
[3] Patent: WO2009/23844, 2009, A2, . Location in patent: Page/Page column 127-128
[4] Patent: US2008/200471, 2008, A1, . Location in patent: Page/Page column 60; 61
[5] Patent: US2010/16297, 2010, A1, . Location in patent: Page/Page column 35
[6] Patent: WO2010/21797, 2010, A1, . Location in patent: Page/Page column 92
[7] Patent: US2010/29629, 2010, A1, . Location in patent: Page/Page column 61
[8] Patent: WO2010/24980, 2010, A1, . Location in patent: Page/Page column 110
[9] Patent: US2010/22581, 2010, A1, . Location in patent: Page/Page column 45; 46
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 75151-82-5 ]

Aryls

Chemical Structure| 74052-89-4

[ 74052-89-4 ]

N-(4-Hydroxyphenyl)pivalamide

Similarity: 0.98

Chemical Structure| 1042580-33-5

[ 1042580-33-5 ]

N-(4-Hydroxyphenyl)-N-methylisobutyramide

Similarity: 0.93

Chemical Structure| 56619-93-3

[ 56619-93-3 ]

N-(3-Methoxyphenyl)pivalamide

Similarity: 0.92

Chemical Structure| 14372-30-6

[ 14372-30-6 ]

N-(4-Hydroxyphenyl)cyclopropanecarboxamide

Similarity: 0.89

Chemical Structure| 1693-37-4

[ 1693-37-4 ]

N-(4-Hydroxyphenyl)propionamide

Similarity: 0.89

Amides

Chemical Structure| 74052-89-4

[ 74052-89-4 ]

N-(4-Hydroxyphenyl)pivalamide

Similarity: 0.98

Chemical Structure| 1042580-33-5

[ 1042580-33-5 ]

N-(4-Hydroxyphenyl)-N-methylisobutyramide

Similarity: 0.93

Chemical Structure| 56619-93-3

[ 56619-93-3 ]

N-(3-Methoxyphenyl)pivalamide

Similarity: 0.92

Chemical Structure| 14372-30-6

[ 14372-30-6 ]

N-(4-Hydroxyphenyl)cyclopropanecarboxamide

Similarity: 0.89

Chemical Structure| 1693-37-4

[ 1693-37-4 ]

N-(4-Hydroxyphenyl)propionamide

Similarity: 0.89